CN100402530C - 作为磷酸酶抑制剂的嘧啶并三嗪 - Google Patents

作为磷酸酶抑制剂的嘧啶并三嗪 Download PDF

Info

Publication number
CN100402530C
CN100402530C CNB028264223A CN02826422A CN100402530C CN 100402530 C CN100402530 C CN 100402530C CN B028264223 A CNB028264223 A CN B028264223A CN 02826422 A CN02826422 A CN 02826422A CN 100402530 C CN100402530 C CN 100402530C
Authority
CN
China
Prior art keywords
ylmethyl
pyrimido
triazine
alkyl
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB028264223A
Other languages
English (en)
Chinese (zh)
Other versions
CN1610683A (zh
Inventor
K·R·格廷
L·Q·塞蒂
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN1610683A publication Critical patent/CN1610683A/zh
Application granted granted Critical
Publication of CN100402530C publication Critical patent/CN100402530C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
CNB028264223A 2001-12-27 2002-12-27 作为磷酸酶抑制剂的嘧啶并三嗪 Expired - Fee Related CN100402530C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US34393701P 2001-12-27 2001-12-27
US60/343,937 2001-12-27
US39911002P 2002-07-26 2002-07-26
US60/399,110 2002-07-26

Publications (2)

Publication Number Publication Date
CN1610683A CN1610683A (zh) 2005-04-27
CN100402530C true CN100402530C (zh) 2008-07-16

Family

ID=26993696

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB028264223A Expired - Fee Related CN100402530C (zh) 2001-12-27 2002-12-27 作为磷酸酶抑制剂的嘧啶并三嗪

Country Status (19)

Country Link
US (1) US6642381B2 (cg-RX-API-DMAC7.html)
EP (1) EP1467996B1 (cg-RX-API-DMAC7.html)
JP (1) JP4188839B2 (cg-RX-API-DMAC7.html)
KR (1) KR100601769B1 (cg-RX-API-DMAC7.html)
CN (1) CN100402530C (cg-RX-API-DMAC7.html)
AT (1) ATE311388T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002367190B2 (cg-RX-API-DMAC7.html)
BR (1) BR0215395A (cg-RX-API-DMAC7.html)
CA (1) CA2471265C (cg-RX-API-DMAC7.html)
DE (1) DE60207759T2 (cg-RX-API-DMAC7.html)
ES (1) ES2252554T3 (cg-RX-API-DMAC7.html)
JO (1) JO2242B1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04006266A (cg-RX-API-DMAC7.html)
PA (1) PA8562901A1 (cg-RX-API-DMAC7.html)
PE (1) PE20030896A1 (cg-RX-API-DMAC7.html)
PL (1) PL371180A1 (cg-RX-API-DMAC7.html)
TW (1) TW200306313A (cg-RX-API-DMAC7.html)
UY (1) UY27606A1 (cg-RX-API-DMAC7.html)
WO (1) WO2003055883A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1439834A1 (en) * 2001-10-30 2004-07-28 Applied Research Systems ARS Holding N.V. Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps)
PL377620A1 (pl) 2002-11-18 2006-02-06 F. Hoffmann-La Roche Ag Diazynopirymidyny
US20040186151A1 (en) * 2003-02-12 2004-09-23 Mjalli Adnan M.M. Substituted azole derivatives as therapeutic agents
AU2004210711B2 (en) * 2003-02-12 2010-07-08 Transtech Pharma, Inc. Substituted azole derivatives as therapeutic agents
WO2005080346A1 (en) * 2004-02-12 2005-09-01 Transtech Pharma, Inc. Substituted azole derivatives, compositions, and methods of use
US20080125403A1 (en) 2004-04-02 2008-05-29 Merck & Co., Inc. Method of Treating Men with Metabolic and Anthropometric Disorders
EP1991544B1 (en) * 2006-01-30 2018-08-15 vTv Therapeutics LLC Substituted imidazole derivatives and their use as ptpase inhibitors
WO2008151257A2 (en) 2007-06-04 2008-12-11 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
ES2627848T3 (es) 2008-06-04 2017-07-31 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros trastornos
ES2624828T3 (es) 2008-07-16 2017-07-17 Synergy Pharmaceuticals Inc. Agonistas de la guanilato ciclasa útiles para el tratamiento de trastornos gastrointestinales, inflamación, cáncer y otros
WO2010083645A1 (en) * 2009-01-21 2010-07-29 Shanghai Targetdrug Co., Ltd PYRIMIDO[5,4-e][1,2,4]TRIAZINES AND USES THEREOF
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9486433B2 (en) 2012-10-12 2016-11-08 Mochida Pharmaceuticals Co. Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
US9708367B2 (en) 2013-03-15 2017-07-18 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase and their uses
EP2968439A2 (en) 2013-03-15 2016-01-20 Synergy Pharmaceuticals Inc. Compositions useful for the treatment of gastrointestinal disorders
KR20150127599A (ko) 2013-03-15 2015-11-17 모치다 세이야쿠 가부시키가이샤 비알코올성 지방간염을 치료하기 위한 조성물 및 방법
US10441560B2 (en) 2013-03-15 2019-10-15 Mochida Pharmaceutical Co., Ltd. Compositions and methods for treating non-alcoholic steatohepatitis
PL3004138T3 (pl) 2013-06-05 2024-07-29 Bausch Health Ireland Limited Ultra-oczyszczeni agoniści peptydowi cyklazy guanylanowej C, sposób ich uzyskiwania i ich zastosowanie

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1236780A (zh) * 1998-03-11 1999-12-01 弗·哈夫曼-拉罗切有限公司 吡唑并嘧啶和吡唑并三嗪
WO1999065909A1 (en) * 1998-06-19 1999-12-23 Pfizer Products Inc. PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022079D0 (en) 2000-09-08 2000-10-25 Inst Of Molecul & Cell Biology Novel protein tyrosine phosphatase inhibitor

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1236780A (zh) * 1998-03-11 1999-12-01 弗·哈夫曼-拉罗切有限公司 吡唑并嘧啶和吡唑并三嗪
WO1999065909A1 (en) * 1998-06-19 1999-12-23 Pfizer Products Inc. PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
. HENRIK SUNE ANDERSEN ET AL.J. BIO. CHEM.,Vol.275 No.10. 2000 *

Also Published As

Publication number Publication date
ES2252554T3 (es) 2006-05-16
PA8562901A1 (es) 2003-07-28
DE60207759D1 (de) 2006-01-05
DE60207759T2 (de) 2006-08-03
EP1467996A1 (en) 2004-10-20
CA2471265A1 (en) 2003-07-10
JP4188839B2 (ja) 2008-12-03
TW200306313A (en) 2003-11-16
JO2242B1 (en) 2004-10-07
BR0215395A (pt) 2004-12-07
JP2005517677A (ja) 2005-06-16
KR20040068981A (ko) 2004-08-02
PE20030896A1 (es) 2003-11-05
ATE311388T1 (de) 2005-12-15
WO2003055883A1 (en) 2003-07-10
CN1610683A (zh) 2005-04-27
KR100601769B1 (ko) 2006-07-19
EP1467996B1 (en) 2005-11-30
US6642381B2 (en) 2003-11-04
AU2002367190B2 (en) 2006-10-05
UY27606A1 (es) 2003-06-30
US20030153756A1 (en) 2003-08-14
PL371180A1 (en) 2005-06-13
AU2002367190A1 (en) 2003-07-15
MXPA04006266A (es) 2004-09-27
CA2471265C (en) 2010-02-09

Similar Documents

Publication Publication Date Title
EP1467996B1 (en) Pyrimidotriazines as phosphatase inhibitors
RU2305682C2 (ru) Производные 4-амино-5-фенил-7- циклобутилпирроло[2,3-d]пиримидина
US8536339B2 (en) AZA-indoles and related compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
CN1202105A (zh) 2-烷基吡咯烷化合物
MXPA05005406A (es) Compuestos quimicos novedosos.
HUT61984A (en) Process for producing condensed imidazole derivatives and pharmaceutical compositions comprising same
CN102584799A (zh) 含氮的6-员芳香环化合物
EP1066278A1 (en) Imidazolone anorectic agents: iii. heteroaryl derivatives
US7098220B2 (en) Imidazopyridine derivatives, preparation method and pharmaceutical compositions containing same
CN1387530A (zh) 用作磷酸二酯酶vii抑制剂的咪唑并吡啶衍生物
HU201955B (en) Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions comprising such compounds
JP4717210B2 (ja) 男性の勃起機能障害の処置のための5−ヘテロシクリルピラゾロ[4,3−d]ピリミジン−7−オン
US3822262A (en) Phenyl acetylimino-imidazolines and-hexahydropyrimidines
WO2003024946A2 (en) Oxamate derivatives containing a variously substituted nitrogen heterocycle
CN1189834A (zh) 具有5-ht受体亲和性的稠合噻唑衍生物
CN1014992B (zh) 喹唑啉二酮和吡啶并嘧啶二酮的制备方法
JP4477010B2 (ja) タンパク質チロシンホスファターゼ阻害剤としてのジアミノピロロキナゾリン化合物
JP2009509963A (ja) 新規化合物
RU2289583C2 (ru) Пиримидотриазины, способ их получения, фармацевтическая композиция на их основе и применение
JPH0662608B2 (ja) カルボスチリル誘導体
CN100334088C (zh) 作为蛋白质酪氨酸磷酸酶抑制剂的二氨基吡咯并喹唑啉化合物
IE902980A1 (en) Substituted n-heterocyclic groups, the preparation and use¹thereof
EP0560231B1 (en) Pyrazolo(3,4-a)acridine derivatives as analgesics
CN1107844A (zh) 二氢化茚衍生物和其制法及合成该衍生物的中间体
IE43551B1 (en) Naphthyridine derivatives

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080716

Termination date: 20111227